Supported Studies

In 2019, we were proud to contribute $1,000,000 to find a cure for children with cancer. We work closely with our partners to co-fund the most promising research projects across the country. Our partners include Alex’s Lemonade Stand Foundation, Bear Necessities Pediatric Cancer Foundation, The Children’s Tumor Foundation and Velosano at the Cleveland Clinic.

2019 research studies:

The Children’s Hospital of Philadelphia
Philadelphia, PA
Garrett Brodeur, MD
Neuroblastoma, Sarcomas
Multivalent nanomedicine to treat high-risk pediatric solid tumors
Funding Partner: Alex’s Lemonade Stand Foundation

Dana-Farber Cancer Institute
Boston, MA
Mariella Filbin, MD/PhD
Brain tumor, Glioma, Glioblastoma
Exploiting the differentiation potential of pediatric high-grade glioma to discover novel therapeutic opportunities
Funding Partner: Alex’s Lemonade Stand Foundation

The Regents of the University of Michigan
Ann Arbor, MI
Costas Lyssiotis, PhD
Diffuse Intrinsic Pontine Glioma (DIPG)
Therapeutic targeting of the disrupted metabolic state in DIPG
Funding Partner: Alex’s Lemonade Stand Foundation

Medical University of South Carolina
Columbia, SC
Meenal Mehrotra, MD/PhD
Osteosarcoma
CD36-Sphingosoine 1-Phosphate Axis in Osteosarcoma progression
Funding Partner: Alex’s Lemonade Stand Foundation

Washington University
St. Louis, MO
Nicole Brossier, MD/PhD
Brain Tumor, Pediatric low-grade Astrocytoma
Defining the molecular mechanisms underlying pediatric brain tumor penetrance
Funding Partner: Alex’s Lemonade Stand Foundation

Research Institute at Nationwide Children’s Hospital
Columbus, OH
Rhabdomyosarcoma, Glioma, Astrocytoma
Dawn Chandler, PhD
Using splice splitting oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy
Funding Partner: Alex’s Lemonade Stand

University Health Center
Toronto, Ontario, Canada
Raymond Kim, MD
MPNST tumors, Plexiform neurofibroma, Optic glioma, CNS tumors
Cell-free DNA as a biomarker in NF1
Funding Partner: The Children’s Tumor Foundation

University of Texas
Houston, TX
Keila Torres, MD/PhD
MPNST tumors
Targeting DNA damage signaling and epigenetic deregulation as a combination therapy for malignant peripheral nerve sheath tumors
Funding Partner: The Children’s Tumor Foundation

*Research distributions were made to our charity partners in December 2019. Some research projects are still under medical board review and once approved, will receive the funds by March 2020.

Visit our Amazon Smile wish list more

Give a Fire 7 tablet to hospitalized children with cancer

Spread the wordgo

Send a personal appeal to your friends and family.

FORM